Short-term outcomes of double omentopexy in OAGB: A Controlled Clinical Trial

Short-term outcomes of double omentopexy in one anastomosis gastric bypass surgery: A Controlled Clinical Trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202203637285531

Enrollment

Registered

2022-03-10

Start date

2022-03-15

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutritional, Metabolic, Endocrine

Interventions

Double omentopexy group

Standard group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: BMI = 40. BMI 35 – 40 with obesity-related comorbidities (e.g. hypertension, hyperlipidemia, type 2 diabetes mellitus, obstructive sleep apnea, obesity hypoventilation syndrome, non-alcoholic fatty liver disease, gastroesophageal reflux disease, and severe arthritis). Able to be committed to follow-up.

Exclusion criteria

Exclusion criteria: - Previous upper GIT surgery or liver cirrhosis. - On oral steroid therapy. - Previous bariatric surgery. - Not fit for general anesthesia (e.g. patients with severe heart disease or untreatable coagulopathies). - Contraindications for insufflation as those with severe cardiovascular or severe restrictive respiratory diseases. - Significant abdominal ventral hernia. - Major psychiatric illness. - Pregnancy

Design outcomes

Primary

Measure	Time frame
Post-operative bleeding;Gastric twist ;Hospital stay	—

Secondary

Measure	Time frame
post-operative reflux ;Excess body weight loss	—

Countries

Egypt

Contacts

Public ContactElsayedamr Basma

Patient Information Manager

elsayedamr@yahoo.com00201223106023

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026